Investing.com - Dr. Reddy’s Labs ADR reported on Friday second quarter earnings that beat analysts' forecasts and revenue that topped expectations.
Dr. Reddy’s Labs ADR announced earnings per share of 0.7961 on revenue of 769.17M. Analysts polled by Investing.com anticipated EPS of 0.5552 on revenue of 696.38M.
Dr. Reddy’s Labs ADR shares are down 13.69% from the beginning of the year, still down 18.50% from its 52 week high of 75.50 set on July 2. They are under-performing the EUR/USD which is down 0% from the start of the year.
Dr. Reddy’s Labs ADR shares gained 0.75% in intra-day trade following the report.
Dr. Reddy’s Labs ADR follows other major Healthcare sector earnings this month
Dr. Reddy’s Labs ADR's report follows an earnings beat by J&J on October 19, who reported EPS of 2.6 on revenue of 23.34B, compared to forecasts EPS of 2.35 on revenue of 23.64B.
Thermo Fisher Scientific had beat expectations on Wednesday with third quarter EPS of 5.76 on revenue of 9.33B, compared to forecast for EPS of 4.68 on revenue of 8.33B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar